Have a personal or library account? Click to login
Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand Cover

Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand

Open Access
|Dec 2012

References

  1. 1 National Centre in HIV Epidemiology and Clinical Research HIV/AIDS, Viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2008 2008 University of New South Wales, Sydney, NSW National Centre in HIV Epidemiology and Clinical Research
  2. 2 Nesdale A Baker M Gane E Kemp R Brunton C Law M Hepatitis C infection in New Zealand: estimating the current and future prevalence and impact 2000 Wellington ESR Report for Ministry of Health
  3. 3 New Zealand Ministry of Health Your Health Topic, Diseases and Illnesses, Hepatitis C [webpage on the internet]. [cited 2012 July 17; updated 2012 5 July]. Available from: http://www.health.govt.nz/yourhealth-topics/diseases-and-illnesses/hepatitis-c
  4. 4 Henderson C Brunton C Lauzon C 2009 National Needle Exchange Blood Borne Virus Seroprevalence Study. Final Report prepared for the NZ Ministry of Health 2011 2011 NZ Ministry of Health
  5. 5 Aceijas C Rhodes T Global estimates of prevalence of HCV infection among injecting drug users International Journal of Drug Policy 2007 18 352 8
  6. 6 Sheerin IG Green FT Sellman JD What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand? Drug and Alcohol Review 2004 23 3 261 72
  7. 7 Fried MW Shiffman ML Reddy KR Smith C Marinos G Goncales FL Jr Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection New England Journal of Medicine 2002 347 975 82
  8. 8 Manns MP McHutchison JG Gordon SC Rustgi VK Shiffman M Reindollar R Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 2001 358 958 65
  9. 9 Grebely J Genoway K Khara M Duncan F Viljoen M Elliott D Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection International Journal of Drug Policy 2007 18 5 437 43
  10. 10 The Kirby Institute HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2011 2011 Sydney, NSW The Kirby Institute, the University of New South Wales
  11. 11 Grebely J Bryant J Hull P Hopwood M Lavis Y Dore GJ Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia Journal of Viral Hepatitis 2011 18 4 104 16
  12. 12 Butt G Patterson B McGuiness L Living with the stigma of hepatitis C Western Journal of Nursing Research 2008 30 2 204 21
  13. 13 Link BG Phelan JC Stigma and its public health implications Lancet 2006 367 528 9
  14. 14 Treloar C Rhodes T The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis Qualitative Health Research 2009 19 9 1321 34
  15. 15 Anti-Discrimination Board of New South Wales C-Change. Report of the Enquiry into Hepatitis C-related Discrimination 2001 Sydney Anti-Discrimination Board of New South Wales
  16. 16 Kurtz SP Surratt HL Kiley MC Inciardi JA Barriers to health and social services for street-based sex workers Journal of Health Care for the Poor and Underserved 2005 16 345 61
  17. 17 Pascoe EA Smart Richman L Perceived discrimination and health: a meta-analytic review Psychological Bulletin 2009 135 531 54
  18. 18 Wilson H Hopwood M Hull P Lavis Y Newland J Bryant J Treatment decisions: what makes people decide to have treatment for hepatitis C? 2010 Sydney National Centre in HIV Social Research, The University of New South Wales
  19. 19 Kinsler JJ Wong MD Sayles JN Davis C Cunningham WE The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population AIDS Patient Care and STDs 2007 21 8 584 92
  20. 20 Sayles JN Hays RD Sarkisian CA Mahajan AP Spritzer KL Cunnigham WE Development and psychometric assessment of multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults Aids and Behavior 2008 12 748 58
  21. 21 Litwin AH Kunins HV Berg KM Federman AD Heavner KK Gourevitch MN Hepatitis C management by addiction medicine physicians: results from a national survey Journal of Substance Abuse Treatment 2007 33 99 105
  22. 22 Morrill JA Shrestha M Grant RW Barriers to the treatment of hepatitis C Patient, provider, and system factors. Journal of General Internal Medicine 2005 20 754 8
  23. 23 Thompson VV Ragland KE Hall CS Morgan M Bangsberg DR Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons AIDS 2005 19 3 s208 14
  24. 24 Hopwood M Treloar C Receiving a hepatitis C – positive diagnosis Internal Medicine Journal 2004 34 9 526 31
  25. 25 Loxley W Davidson P Heale P Sullivan P Drawing blood: injecting drug users, blood borne viruses, testing and vaccinations 2000 Perth National Drug Research Institute, Curtin University of Technology
  26. 26 Treloar C Newland J Harris M Deacon R Maher L Providing a better hepatitis C diagnosis: insights from a qualitative study of recent seroconverters Australian Family Physician 2010 39 8 589 92
  27. 27 Teesson M Proudfoot H Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment 2003 Canberra Australian Government Department of Health and Ageing
  28. 28 Sladden TJ Hickey AR Dunn TM Beard JR Hepatitis C virus infection: impacts on behaviour and lifestyle Australia and New Zealand Journal of Public Health 1998 22 4 509 11
  29. 29 Hickman IJ Clouston AD MacDonald GA Purdie DM Prins JB Ash S Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C An International Journal of Gastroenterology and Hepatology 2002 51 89 94
  30. 30 Ueno T Sugawara H Sujaku K Hashimoto O Tsuji R Torimura T Therapeutic effects of restricted diet and exercise in obese patients with fatty liver Journal of Hepatology 1997 27 103 7
  31. 31 Grebely J Raffa J Lai C Krajden M Fischer B Kerr T Low uptake of treatment for hepatitis C virus (HCV) infection in a large community-based cohort of illicit drug users in Vancouver Hepatology 2007 46 296A
  32. 32 McNally S Temple-Smith M Pitts M Making decisions about hepatitis C treatment (Monograph Series No. 49) 2004 Melbourne La Trobe University
  33. 33 Treloar C Holt M Drug treatment clients’ readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings Australian Health Review 2008 32 570 6
  34. 34 Tait JM McIntyre PG McLeod S Nathwani D Dillon JF The impact of a managed care network on attendance, follow-up and treatment of a hepatitis C specialist centre Journal of Viral Hepatitis 2010 17 698 704
  35. 35 Shatin D Schech SD Patel K McHutchison JG Population-based hepatitis C surveillance and treatment in a national managed care organization The American Journal of Managed Care 2004 10 250 6
  36. 36 Knott A Dieperink E Willenbring ML Heit S Durfee JM Wingert M Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes American Journal of Gastroenterology 2006 101 2254 62
  37. 37 Novick D Kreek MJ Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients Addiction 2008 103 6 905 18
  38. 38 Ho SB Groessl E Dollarhide A Robinson S Kravetz D Dieperink E Management of chronic hepatitis C in Veterans: the potential of integrated care models The American Journal of Gastroenterology 2008 103 1810 23
  39. 39 Hellard M Wang Y The role of general practitioners in managing and treating hepatitis C Medical Journal of Australia 2009 191 10 523 4
  40. 40 Norman J Walsh N Mugavin J Stoove M Kelsall J Austin K The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users Harm Reduction Journal 2008 5 8
  41. 41 Sylvestre D Zweben J Integrating HCV services for drug users: a model to improve engagement and outcomes International Journal of Drug Policy 2007 18 5 406 10
  42. 42 Department of Health, Western Australia Hepatitis C Virus Model of Care 2009 Perth Health Networks Branch, Department of Health, Western Australia
  43. 43 Ward P Coates A We shed tears, but there is no one there to wipe them up for us’: narratives of (mis)trust in a materially deprived community Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 2006 10 3 283 301
  44. 44 Ostertag S Wright B Broadhead R Altice F Trust and other characteristics associated with health care utilization by injection drug users The Journal of Drug Issues 2006 36 4 935 74
  45. 45 Jauffret-Roustide M Cohen J Poisot-Martin I Spire B Gossop M Carrieri M Distributive sharing among HIV–HCV co-infected injecting drug users: the preventive role of trust in one’s physician AIDS Care 2012 24 2 232 8
  46. 46 Hepworth J Krug G A socio-cultural perspective on the effects of a new virus on a community’s health Journal of Health Psychology 1999 4 2 237 46
  47. 47 Glacken M Kernohan G Coates V Diagnosed with hepatitis C: a descriptive exploratory study International Journal of Nursing Studies 2001 38 107 16
  48. 48 Treloar C Fraser SM Hepatitis C treatment in pharmacotherapy services: increasing treatment uptake needs a critical view Drug & Alcohol Review 2009 28 4 436 40
  49. 49 O’Brien S Day C Black E Dolan K Injecting drug users’ understanding of hepatitis C Addictive Behaviors 2008 33 12 1602 5
  50. 50 Stein MD Maksad J Clarke J Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment Drug and Alcohol Dependence 2001 61 3 211 5
  51. 51 Treloar C Hull P Bryant J Hopwood M Grebely J Lavis Y Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs Drug and Alcohol Dependence 2011 116 1–3 52 6
  52. 52 Treloar C Hull P Dore GJ Grebely J Knowledge and barriers associated with assessment and willingness to have treatment for hepatitis C virus infection among people who inject drugs Drug and Alcohol Review 2012 31 7 918 24
  53. 53 Cleary PD Satisfaction may not suffice! A commentary on ‘A patient’s perspective’ International Journal of Technology Assessment in Health Care 1998 14 1 35 7
  54. 54 Fry CL Hall W Ritter A Jenkinson R The ethics of paying drug users who participate in a research. A review and practical recommendation Journal of Empirical Research on Human Research Ethics: An International Journal 2006 1 4 21 36
DOI: https://doi.org/10.5334/ijic.819 | Journal eISSN: 1568-4156
Language: English
Submitted on: Dec 1, 2011
Accepted on: Jun 21, 2012
Published on: Dec 11, 2012
Published by: Igitur, publishing
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Robyn Horwitz, Loren Brener, Carla Treloar, published by Igitur, publishing
This work is licensed under the Creative Commons Attribution 4.0 License.